Product Categories
| Country: | China |
|---|---|
| Tel: | +86-530-529 6766，+86-15666160102 |
| Mobile: | 15666160102 |
| E-mail: | |
| QQ: | |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| LDN-193189 HCl | C25H23ClN6 | 1062368-62-0 | Details |
| Hexanoic acid,3-(aminomethyl)-5-methyl-, (3R)- | C8H17NO2 | 148553-51-9 | Details |
| Mc-Val-Cit-PAB | C28H40N6O7 | 159857-80-4 | Details |
| Monomethylauristatin E | C39H67N5O7 | 474645-27-7 | Details |
| CNX-774 | C26H22FN7O3 | 1202759-32-7 | Details |
| Fmoc-Val-Cit-PAB | C33H39N5O6 | 159858-22-7 | Details |
| LDC1267 | C30H26F2N4O5 | 1361030-48-9 | Details |
| Boc-Dap-NE | C23H36N2O5 | 160800-65-7 | Details |
| 9a-(4-chlorobenzyl)-7-hydroxy-4-(4-(2-(piperidin-1-yl)ethoxy)phenyl)-1,2,9,9a-tetrahydro-3H-fluoren-3-one | C33H34ClNO3 | 851107-28-3 | Details |
| DOTA-HYNIC-PSMA(inhibitor) | Details |
| SU6656 | C19H21N3O3S | 330161-87-0 | Details |
| 2-CHLORO-5-FORMYL-4-PICOLINE | C7H6ClNO | 884495-38-9 | Details |
| PLERIXAFOR | C28H54N8 | 110078-46-1 | Details |
| NSC 632839 | C21H21NO.ClH | 157654-67-6 | Details |
| YO-01027 (Dibenzazepine) | C26H23F2N3O3 | 209984-56-5 | Details |
| (2,5-dimethylthiophen-3-yl)boronic acid | C6H9BO2S | 162607-23-0 | Details |
| SCH772984 | C33H33N9O2 | 942183-80-4 | Details |
| 4-amino-2-chloronicotinaldehyde | C6H5ClN2O | 338452-92-9 | Details |
| 6-Bromo-2-methylpyridine-3-carboxaldehyde | C7H6BrNO | 926293-55-2 | Details |
| R1487 | C19H19ClF2N4O3 | 449808-64-4 | Details |
| VR23 | C19H16ClN5O6S | 1624602-30-7 | Details |
| FIIN-3 | C34H36Cl2N8O4 | 1637735-84-2 | Details |
| RK-33 | C23H20N6O3 | 1070773-09-9 | Details |
| HYNIC-Tyr3-Octreotide | Details |
| Akti-1/2 | C34H29N7O | 612847-09-3 | Details |
| LY-411575 | C26H23F2N3O4 | 209984-57-6 | Details |
| NSC-144303 | C19H14N2O7S | 108477-18-5 | Details |
| LDN-193189 | C25H22N6 | 1062368-24-4 | Details |
| 2-AMino-3-forMyl-4-chloropyridine | C6H5ClN2O | 884004-48-2 | Details |
| Tideglusib | C19H14N2O2S | 865854-05-3 | Details |
| MMAD | C41H66N6O6S | 203849-91-6 | Details |
| Mc-Val-Cit-PAB-MMAE | C68H105N11O15 | 646502-53-6 | Details |
| poziotinib | C23H21Cl2FN4O3 | 1092364-38-9 | Details |
| K-Ras(G12C) inhibitor | C15H17ClIN3O3 | 1469337-95-8 | Details |
| DOTA-Tyr3-Octreotide | C65H92N14O18S2 | 204318-14-9 | Details |
| Val-Cit-PAB-MMAE | C58H94N10O12 | 644981-35-1 | Details |
| YC-1 | C19H16N2O2 | 170632-47-0 | Details |
| (+)-MK 801 hydrogen maleate | C20H19NO4 | 77086-22-7 | Details |
| Rhodamine 123 | C21H17ClN2O3 | 62669-70-9 | Details |
| 2-Bromo-5-formyl-3-methylpyridine | C7H6BrNO | 885167-81-7 | Details |
| PD98059 | C16H13NO3 | 167869-21-8 | Details |
| MK 0557 | C22H19FN4O3 | 328232-95-7 | Details |
| Mc-Val-Cit-PAB-PNP | C35H43N7O11 | 159857-81-5 | Details |
| FMoc-Val-Cit-PAB-MMAE | C73H104N10O14 | 1350456-56-2 | Details |
| MG-132 | C26H41N3O5 | 133407-82-6 | Details |
| 4-BENZYLOXYBUTYRIC ACID | C11H14O3 | 10385-30-5 | Details |
| Hispidin | C13H10O5 | 555-55-5 | Details |
| Bz-Arg-Et | C15H22N4O3 | 971-21-1 | Details |
| AMI-1 | C21H17N2NaO9S2 | 20324-87-2 | Details |
| 2-Pyridineacetic acid, 6-methyl- (9CI) | C8H9NO2 | 92917-49-2 | Details |
| 1-(AMINOMETHYL)CYCLOPROPANECARBOXYLIC ACID | C5H9NO2 | 139126-45-7 | Details |
| (R)-2-(4-cyclopropylphenyl)-N-(1-(5-(2,2,2-trifluoroethoxy)pyridin-2-yl)ethyl)acetamide | C20H21F3N2O2 | 953778-63-7 | Details |
| HYNIC-PSMA(inhibitor) | Details |
| 6-bromo-4-chlorothieno[3,2-d]pyrimidine | C6H2BrClN2S | 225385-03-5 | Details |
| Dp44mT | C14H15N5S | 152095-12-0 | Details |
| Refametinib | C19H20F3IN2O5S | 923032-37-5 | Details |
| BAY 80-6946 | C23H28N8O4 | 1032568-63-0 | Details |
| 6-BroMo-4-Methyl-pyridine-3-carbaldehyde | C7H6BrNO | 926294-07-7 | Details |
| Mc-MMAE | C49H78N6O10 | 863971-24-8 | Details |
| APY29 | C17H16N8 | 1216665-49-4 | Details |
| 4-(dimethylamino)-4-phenylcyclohexan-1-one | C14H19NO | 65619-20-7 | Details |
| (-)-MK 801 hydrogen maleate | C20H19NO4 | 121917-57-5 | Details |
| Hoechst 34580 | C27H29N7 | 23555-00-2 | Details |
| AMG-47a | C29H28F3N5O2 | 882663-88-9 | Details |
| FH535 | C13H10Cl2N2O4S | 108409-83-2 | Details |
| MMAF | C39H65N5O8 | 745017-94-1 | Details |
| Voxtalisib | C13H14N6O | 934493-76-2 | Details |
| Fmoc-3vvd-OH | C36H51N3O7 | 863971-44-2 | Details |
| Tariquidar | C38H38N4O6 | 206873-63-4 | Details |
| 5-CHLORO-2-(CHLOROMETHYL)PYRIDINE | C6H5Cl2N | 10177-24-9 | Details |
| MK-2206 2HCl | C25H22ClN5O | 1032350-13-2 | Details |
| Emd1214063 | C29H28N6O2 | 1100598-32-0 | Details |
| Dorsomorphin 2HCl （BML-275 2HCl） | C24H27Cl2N5O | 1219168-18-9 | Details |
| BAY85-3934 | C13H14N8O2 | 1154028-82-6 | Details |
| 5-(2-amino-4-oxo-3-(2-(trifluoromethyl)phenyl)-3,4-dihydroquinazolin-6-yl)-N-(2,4-difluorophenyl)-2-methoxypyridine-3-sulfonamide | C27H18F5N5O4S | 1384097-27-1 | Details |
| (1R)-1-[5-(2,2,2-trifluoroethoxy)-2-pyridyl]ethanamine | C9H11F3N2O | 953780-33-1 | Details |
| DOTA-PSMA(inhibitor) | Details |
| (E)-3-[4-[[2,4-bis(trifluoromethyl)phenyl]methoxy]-3-methoxyphenyl]-2-cyano-N-[5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl]prop-2-enamide | C23H13F9N4O3S | 725247-18-7 | Details |
| 3,5-diamino-N-(N'-benzylcarbamimidoyl)-6-chloropyrazine-2-carboxamide,hydrochloride | C13H15Cl2N7O | 161804-20-2 | Details |
| 4-cyclopropylphenylacetic acid | C11H12O2 | 40641-90-5 | Details |
| EAI045 | C19H14FN3O3S | 1942114-09-1 | Details |
| CeMMEC13 | C19H16N2O4 | 1790895-25-8 | Details |
| Saccharin 1-methylimidazole (SMI) | C11H11N3O3S | 482333-74-4 | Details |
| CeMMEC1 | C19H16N2O4 | 440662-09-9 | Details |
| 2-(3,6-diacetyloxy-2,7-dichloro-9H-xanthen-9-yl)benzoic acid | C24H16Cl2O7 | 4091-99-0 | Details |
| BML-275 | C24H25N5O | 866405-64-3 | Details |
| LY 294002 | C19H18ClNO3 | 934389-88-5 | Details |
| 4-Chlorothieno[3,2-d]pyrimidine | C6H3ClN2S | 16269-66-2 | Details |
| LY2603618 | C18H22BrN5O3 | 911222-45-2 | Details |
| (5Z)-5-[(2,5-dimethyl-1-pyridin-3-ylpyrrol-3-yl)methylidene]-3-phenyl-1,3-thiazolidine-2,4-dione | C21H17N3O2S | 677331-12-3 | Details |
| NSC348884 | C38H40N10 | 81624-55-7 | Details |
| Val-Cit-PAB | C18H29N5O4 | 159857-79-1 | Details |
| SGI-7079 | C26H26FN7 | 1239875-86-5 | Details |
| Fmoc-Val-Cit-PAB-PNP | C40H42N6O10 | 863971-53-3 | Details |
| DCC2701 (Altiratinib) | C26H21F3N4O4 | 1345847-93-9 | Details |
| AZ6102 | C25H28N6O | 1645286-75-4 | Details |
| BAW2881 | C22H15F3N4O2 | 861875-60-7 | Details |
| EPI-001 | C21H27ClO5 | 227947-06-0 | Details |
| 3-IODO-4-METHOXY-PYRIDIN-2-YLAMINE | C6H7IN2O | 956485-64-6 | Details |
| Dolastatin 10 | C42H68N6O6S | 110417-88-4 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 6 7 8 9 | ||||